Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD

. 2015 Jul 31;10(7):e0134776. doi: 10.1371/journal.pone.0134776

PMCID: PMC4521847 PMID: 26230317

The following information is missing from the Funding section: This study was also funded by the Roskamp Foundation.

Reference

1. Verma M, Beaulieu-Abdelahad D, Ait-Ghezala G, Li R, Crawford F, Mullan M, et al. (2015) Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. PLoS ONE 10(5): e0128224 doi: 10.1371/journal.pone.0128224 [DOI] [PMC free article] [PubMed] [Google Scholar]